Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Melanoma × cemiplimab × Clear all

Phase

Status

Recruiting 5 Completed 5 Terminated 3 Active not recruiting 3 Unknown 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

cemiplimab 1 Ruthenium-106 1 Radiotherapy 1 Melphalan 1 Electrocardiography 1 Echocardiography 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06848088 2026-01-12

A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

Regeneron Pharmaceuticals

Phase 2 Enrolling by invitation

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡